PRLog - Jan. 4, 2013 - The 9th Annual Asthma & COPD event comes at a perfect time to discuss latest developments and challenges alongside strategies to improve patient outcomes. By attending this event delegates will be able to learn the challenges and successes of peers and apply this knowledge to businesses, gaining the most efficient ways to move forward.
Asthma & COPD
SMi is pleased to confirm Liz Hardaker, Investigator 11, Novartis as speaker of the event
She will discuss current therapies to treat COPD and asthma exacerbations, in vivo models that mimic aspects of COPD and asthma and what are exacerbations of COPD and asthma.
Join SMi at the Copthore Tara Hotel and get advice from an unparalleled speaker faculty on the following key topics that include:
Establishing patient phenotyping for efficient and effective therapeutic outcomes
Overcoming the challenges of clinical trial management and developing novel biomarkers
Spotlight on inhalation devices and combination therapies
Comparing and contrasting exacerbations of asthma & COPD alongside treatment options
Drawing attention to chemokine antagonists and anti-cytokine therapies
Overcoming steroid resistance in asthma & COPD
For more information visit http://www.smi-
Or alternatively contact Fateja Begum on +44 0 207 827 6184 or email on firstname.lastname@example.org